NCBioImpact, a public/private partnership created to bring together key resources to produce world-class biopharma ...
US drugmaker Eli Lilly has signed a $2bn deal with a Hong Kong-listed company that uses AI for drug discovery, highlighting ...
A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely ...
Filana Therapeutics, Inc. (NASDAQ: FLNA, "Filana Therapeutics", the "Company"), a biotechnology company focused on developing therapies for Tuberous Sclerosis Complex (TSC)-related epilepsy, today ...
A single-dose of Trogenix’s proprietary Synthetic Super-Enhancers achieved complete tumour elimination in 83% of treated cases with no toxicity over 11 months and no tumour recurrence in a brain ...
The Glassworks campus sits near a cluster of multinational companies and in reach of local government, industry and education ...
Medtronic, Abbott, Boston Scientific, Medical Microinstruments (MMI) and other device developers earned honors at the 2026 ...
Formation Bio CEO Ben Liu is convinced that drug discovery isn’t the bottleneck in getting medicines to market—it’s going ...
The wealthy former biotech executive identifies as a "born again" Catholic who would bring CEO-style management to the state as a “new kind of governor.” ...
• Business Advising with SBDC: 9 a.m.-4 p.m. Wednesday, April 15, Windsor Chamber Office, 421 Main St. Suite A, Windsor.
Global development program for JNJ-1900 (NBTXR3) proceeded as planned, building toward opportunity to address one of the ...
NYSE:MDT: $41.19 million (12.9% of AUM) NASDAQ:MIRM: $33.27 million (10.4% of AUM) NASDAQ:IONS: $33.05 million (10.4% of AUM) NYSE:CI: $26.55 million (8.3% of AUM) NASDAQ:BMRN: $24.48 million (7.7% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results